232 related articles for article (PubMed ID: 27930696)
1. Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study.
Sardarinia M; Akbarpour S; Lotfaliany M; Bagherzadeh-Khiabani F; Bozorgmanesh M; Sheikholeslami F; Azizi F; Hadaegh F
PLoS One; 2016; 11(12):e0167623. PubMed ID: 27930696
[TBL] [Abstract][Full Text] [Related]
2. Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran.
Eslami A; Naghibi Irvani SS; Ramezankhani A; Fekri N; Asadi K; Azizi F; Hadaegh F
BMC Public Health; 2019 Jun; 19(1):719. PubMed ID: 31182076
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose Study.
Afsharian S; Akbarpour S; Abdi H; Sheikholeslami F; Moeini AS; Khalili D; Momenan AA; Azizi F; Hadaegh F
Diabetes Metab Res Rev; 2016 Sep; 32(6):596-606. PubMed ID: 26787367
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific incidence rates and risk factors of premature cardiovascular disease. A long term follow up of the Tehran Lipid and Glucose Study.
Eslami A; Mozaffary A; Derakhshan A; Azizi F; Khalili D; Hadaegh F
Int J Cardiol; 2017 Jan; 227():826-832. PubMed ID: 27829526
[TBL] [Abstract][Full Text] [Related]
5. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study.
Moazzeni SS; Hizomi Arani R; Deravi N; Hasheminia M; Khalili D; Azizi F; Hadaegh F
Cardiovasc Diabetol; 2021 Jul; 20(1):141. PubMed ID: 34253199
[TBL] [Abstract][Full Text] [Related]
6. Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study.
Mirbolouk M; Asgari S; Sheikholeslami F; Mirbolouk F; Azizi F; Hadaegh F
Geriatr Gerontol Int; 2015 Apr; 15(4):449-56. PubMed ID: 24750352
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran lipid and glucose study.
Bozorgmanesh M; Hadaegh F; Sheikholeslami F; Azizi F
J Endocrinol Invest; 2012 Jan; 35(1):14-20. PubMed ID: 21586894
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy.
Joseph P; Kutty VR; Mohan V; Kumar R; Mony P; Vijayakumar K; Islam S; Iqbal R; Kazmi K; Rahman O; Yusuf R; Anjana RM; Mohan I; Rangarajan S; Gupta R; Yusuf S
Eur Heart J; 2022 Aug; 43(30):2831-2840. PubMed ID: 35731159
[TBL] [Abstract][Full Text] [Related]
9. Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study.
Bozorgmanesh M; Hadaegh F; Azizi F
Lipids Health Dis; 2010 Sep; 9():100. PubMed ID: 20846382
[TBL] [Abstract][Full Text] [Related]
10. Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: over a decade of follow-up in the Tehran Lipid and Glucose Study.
Deravi N; Moazzeni SS; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
BMC Public Health; 2022 Sep; 22(1):1762. PubMed ID: 36114528
[TBL] [Abstract][Full Text] [Related]
11. 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study.
Rabani S; Sardarinia M; Akbarpour S; Azizi F; Khalili D; Hadaegh F
PLoS One; 2018; 13(5):e0195543. PubMed ID: 29768511
[TBL] [Abstract][Full Text] [Related]
12. Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy.
Li S; Liu Z; Joseph P; Hu B; Yin L; Tse LA; Rangarajan S; Wang C; Wang Y; Islam S; Liu W; Lu F; Li Y; Hou Y; Qiang D; Zhao Q; Li N; Lei R; Chen D; Han A; Liu G; Zhang P; Zhi Y; Liu C; Yang J; Resalaiti A; Ma H; Ma Y; Liu Y; Xing X; Xiang Q; Liu Z; Sheng Y; Tang J; Liu L; Yusuf S; Li W
Eur Heart J; 2022 Aug; 43(30):2852-2863. PubMed ID: 35731140
[TBL] [Abstract][Full Text] [Related]
13. Metabolic mediators of the impact of general and central adiposity measures on cardiovascular disease and mortality risks in older adults: Tehran Lipid and Glucose Study.
Kazempour-Ardebili S; Ramezankhani A; Eslami A; Akbarpour S; Azizi F; Hadaegh F
Geriatr Gerontol Int; 2017 Nov; 17(11):2017-2024. PubMed ID: 28349639
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study.
Mohammadreza B; Farzad H; Davoud K; Fereidoun Prof AF
Cardiovasc Diabetol; 2012 Mar; 11():20. PubMed ID: 22394430
[TBL] [Abstract][Full Text] [Related]
15. Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong.
Wu H; Lau ESH; Yang A; Zhang X; Fan B; Ma RCW; Kong APS; Chow E; So WY; Chan JCN; Luk AOY
PLoS Med; 2023 Jan; 20(1):e1004173. PubMed ID: 36716342
[TBL] [Abstract][Full Text] [Related]
16. The effect of obesity phenotype changes on cardiovascular outcomes in adults older than 40 years in the prospective cohort of the Tehran lipids and glucose study (TLGS): joint model of longitudinal and time-to-event data.
Sedaghat Z; Khodakarim S; Sabour S; Valizadeh M; Barzin M; Nejadghaderi SA; Azizi F
BMC Public Health; 2024 Apr; 24(1):1126. PubMed ID: 38654182
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
Al-Shamsi S; Regmi D; Govender RD
BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
[TBL] [Abstract][Full Text] [Related]
18. Long-term incidence of cardiovascular outcomes in the middle-aged and elderly with different patterns of physical activity: Tehran lipid and glucose study.
Naseri P; Amiri P; Masihay-Akbar H; Jalali-Farahani S; Khalili D; Azizi F
BMC Public Health; 2020 Nov; 20(1):1654. PubMed ID: 33148219
[TBL] [Abstract][Full Text] [Related]
19. Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study.
Hadaegh F; Derakhshan A; Mozaffary A; Hasheminia M; Khalili D; Azizi F
PLoS One; 2016; 11(3):e0149780. PubMed ID: 26930192
[TBL] [Abstract][Full Text] [Related]
20. Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy.
Lopez-Jaramillo P; Joseph P; Lopez-Lopez JP; Lanas F; Avezum A; Diaz R; Camacho PA; Seron P; Oliveira G; Orlandini A; Rangarajan S; Islam S; Yusuf S
Eur Heart J; 2022 Aug; 43(30):2841-2851. PubMed ID: 35325078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
